关注
Qiangqiang Wei
Qiangqiang Wei
Drug Discovery Scientist of Biochemistry, Vanderbilt University
在 vanderbilt.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Activation of sigma-1 receptor enhanced pericyte survival via the interplay between apoptosis and autophagy: implications for blood–brain barrier integrity in stroke
Y Zhang, X Zhang, Q Wei, S Leng, C Li, B Han, Y Bai, H Zhang, H Yao
Translational stroke research 11, 267-287, 2020
502020
WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice
Y Gao, M Qian, Q Wei, X Duan, S Wang, H Hu, J Liu, C Pan, S Zhang, L Qi, ...
Acta Pharmacologica Sinica 41 (3), 336-347, 2020
282020
Design, synthesis and biological evaluation of novel 2, 3-dihydroquinazolin-4 (1H)-one derivatives as potential fXa inhibitors
J Xing, L Yang, Y Yang, L Zhao, Q Wei, J Zhang, J Zhou, H Zhang
European Journal of Medicinal Chemistry 125, 411-422, 2017
262017
Discovery of potent orally bioavailable WD repeat domain 5 (WDR5) inhibitors using a pharmacophore-based optimization
KB Teuscher, KM Meyers, Q Wei, JJ Mills, J Tian, J Alvarado, J Sai, ...
Journal of medicinal chemistry 65 (8), 6287-6312, 2022
192022
Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors
Q Wei, L Mei, Y Yang, H Ma, H Chen, H Zhang, J Zhou
Bioorganic & medicinal chemistry 26 (14), 3866-3874, 2018
172018
Design, synthesis and biological evaluation of novel chroman derivatives as non-selective acetyl-CoA carboxylase inhibitors
Q Wei, L Mei, P Chen, X Yuan, H Zhang, J Zhou
Bioorganic Chemistry 101, 103943, 2020
52020
Fragment-Based Screen of SARS-CoV-2 Papain-like Protease (PLpro)
AJ Taylor, K Amporndanai, TA Rietz, B Zhao, A Thiruvaipati, Q Wei, ...
ACS Medicinal Chemistry Letters 15 (8), 1351-1357, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–7